You just read:

Dosing of first patient in phase 3 pivotal study of sovateltide (PMZ-1620), a first-in-class investigational product, for acute cerebral ischemic stroke

News provided by

Pharmazz, Inc.

Nov 23, 2019, 17:00 ET